Drug intelligence / Profile preview

1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-2-(methylamino)ethanone

Development stage: Unknown
Modality: Small Molecules

Overview

1-(5-Tert-butyl-1,3,4-oxadiazol-2-yl)-2-(methylamino)ethanone is a synthetic small molecule with the molecular formula C9H15N3O2 and a molecular weight of approximately 197.24 g/mol[7]. It features a tert-butyl-substituted oxadiazole core linked to an ethanone moiety bearing a methylamino group. There is no publicly available information regarding its mechanism of action or clinical indications. The compound appears to be primarily used in research settings and has not been developed as a therapeutic agent for any specific disease[7].

Other names: 2-(Methylamino)-1-[5-(2-methyl-2-propanyl)-1,3,4-oxadiazol-2-yl]ethanoneEthanone, 1-[5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-yl]-2-(methylamino)-STX

Beyond the preview

Go deeper on 1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-2-(methylamino)ethanone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-2-(methylamino)ethanone.

Explore the full profile